Article Cited by others


Prostate cancer epigenetics and its clinical implications

Yegnasubramanian Srinivasan

Year : 2016| Volume: 18| Issue : 4 | Page no: 549-558

   This article has been cited by
1 Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
Arnas Bakavicius,Kristina Daniunaite,Kristina Zukauskaite,Marija Barisiene,Sonata Jarmalaite,Feliksas Jankevicius
Clinical Epigenetics. 2019; 11(1)
[Pubmed]  [Google Scholar] [DOI]
2 UNC5D , suppressed by promoter hypermethylation, inhibits cell metastasis by activating death-associated protein kinase 1 in prostate cancer
Dong Dong,Lufang Zhang,Changsen Bai,Na Ma,Wei Ji,Li Jia,Aimin Zhang,Pengyu Zhang,Li Ren,Yunli Zhou
Cancer Science. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer
Tarek K. Motawi,Hebatallah A. Darwish,Iman Diab,Maged W. Helmy,Mohamed H. Noureldin
Life Sciences. 2018; 198: 71
[Pubmed]  [Google Scholar] [DOI]
4 Genetics and biology of prostate cancer
Guocan Wang,Di Zhao,Denise J. Spring,Ronald A. DePinho
Genes & Development. 2018; 32(17-18): 1105
[Pubmed]  [Google Scholar] [DOI]
5 Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
Catarina Moreira-Barbosa,Daniela Barros-Silva,Pedro Costa-Pinheiro,Jorge Torres-Ferreira,Vera Constâncio,Rui Freitas,Jorge Oliveira,Luís Antunes,Rui Henrique,Carmen Jerónimo
Clinical Epigenetics. 2018; 10(1)
[Pubmed]  [Google Scholar] [DOI]
6 Potential Epigenetic Biomarkers for Prostate Cancer Screening
Jong-Myon Bae
International Neurourology Journal. 2018; 22(2): 142
[Pubmed]  [Google Scholar] [DOI]
7 Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira,Heather H. Cheng,Wassim Abida,Leigh Ellis,Lauren C. Harshman,Daniel E. Spratt,Jonathan W. Simons,Kenneth J. Pienta,Howard R. Soule
The Prostate. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
Matteo Ferro,Paola Ungaro,Amelia Cimmino,Giuseppe Lucarelli,Gian Busetto,Francesco Cantiello,Rocco Damiano,Daniela Terracciano
International Journal of Molecular Sciences. 2017; 18(6): 1146
[Pubmed]  [Google Scholar] [DOI]
9 Cardiovascular assessment for non-cardiac surgery: European guidelines
Edward Gilbert-Kawai,Hugh Montgomery
British Journal of Hospital Medicine. 2017; 78(6): 327
[Pubmed]  [Google Scholar] [DOI]
10 Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2
Q. Li,S. Lu,X. Li,G. Hou,L. Yan,W. Zhang,B. Qiao
Clinical and Translational Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article